Valuation: Bayer AG

Market Cap 46.17B 52.66B 42.56B 39.85B 74.72B 4,968B 76.27B 512B 198B 2,455B 198B 193B 8,513B P/E 2026 *
20x
P/E 2027 * 15.1x
Enterprise Value 77.9B 88.84B 71.8B 67.22B 126B 8,381B 129B 863B 334B 4,142B 334B 326B 14,363B EV / Sales 2026 *
1.71x
EV / Sales 2027 * 1.6x
Free-Float
100%
Yield 2026 *
0.49%
Yield 2027 * 1.34%
1 week+24.21%
Current month+28.66%
1 month+24.21%
3 months+22.84%
6 months+30.77%
Current year+26.99%
1 week 37.69
Extreme 37.69
47.6
1 month 32.96
Extreme 32.96
47.6
Current year 32.96
Extreme 32.96
49.78
1 year 24.8
Extreme 24.805
49.78
3 years 18.38
Extreme 18.378
53.8
5 years 18.38
Extreme 18.378
67.99
10 years 18.38
Extreme 18.378
123.9
Manager TitleAgeSince
Chief Executive Officer 59 2023-05-31
Director of Finance/CFO 57 2026-05-31
Chief Tech/Sci/R&D Officer 59 2021-01-31
Director TitleAgeSince
Director/Board Member 56 2012-03-31
Director/Board Member 66 2022-03-31
Director/Board Member 60 2017-03-31
Date Insider Type Main position Quantity % Market Cap.
Mar. 17Buy

Director

1,530 0.0002%
Mar. 17Buy

Executive/Senior Manager

13,000 0.0013%
Mar. 17Buy

Chairman

2,671 0.0003%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+24.21%+74.24%-6.56% 52.66B
+7.13%+9.97%+55.80%+163.38% 1,077B
+3.99%+11.50%+67.09%+56.27% 613B
+4.20%+17.03%+38.97%+91.19% 448B
+0.99%+4.85%+28.17%+22.04% 332B
+1.82%+8.19%+40.04%+27.45% 293B
+0.22%+6.75%+31.30%+42.64% 286B
+0.73%+8.53%-27.33%-40.29% 215B
+1.56%+6.14%+29.30%+61.91% 193B
+3.26%+3.33%+15.55%+67.87% 159B
Average +2.39%+10.05%+35.31%+48.59% 366.87B
Weighted average by Cap. +3.79%+9.86%+42.22%+79.76%

Financials

2026 *2027 *
Net sales 45.56B 51.96B 42B 39.32B 73.73B 4,902B 75.26B 505B 195B 2,423B 195B 191B 8,400B 46.7B 53.26B 43.05B 40.3B 75.57B 5,024B 77.14B 517B 200B 2,483B 200B 196B 8,610B
Net income 2.17B 2.47B 2B 1.87B 3.51B 233B 3.58B 24.03B 9.3B 115B 9.29B 9.09B 400B 2.96B 3.38B 2.73B 2.55B 4.79B 318B 4.89B 32.8B 12.69B 157B 12.68B 12.4B 546B
Net Debt 31.72B 36.18B 29.24B 27.38B 51.34B 3,413B 52.4B 351B 136B 1,687B 136B 133B 5,849B 28.52B 32.52B 26.29B 24.61B 46.15B 3,068B 47.1B 316B 122B 1,516B 122B 119B 5,258B
Logo Bayer AG
Bayer AG is one of the world's leaders in designing, producing, and marketing pharmaceutical products and agrochemicals. Net sales are distributed by product family as follows: - agrochemicals (47.5%): herbicides, fungicides, insecticides, etc.; - pharmaceutical products (39.1%): intended for the prevention and treatment of cardiovascular and respiratory diseases, diabetes, nervous system disorders, etc.; - OTC products and nutritional supplements (12.7%); - other (0.7%). Net sales are distributed geographically as follows: Germany (5.7%), Switzerland (1%), Europe-Middle East-Africa (22.9%), United States (33.1%), North America (3.6%), China (7.6%), Asia-Pacific (8.9%), Brazil (9.6%), and Latin America (7.6%).
Employees
87,757
Date Price Change Volume
26-06-26 €47.00 0.00% 7,723,274
26-06-25 €47.00 +18.72% 10,469,144
26-06-24 €39.59 +2.56% 3,571,790
26-06-23 €38.60 +1.10% 2,443,311
26-06-22 €38.18 +0.90% 3,356,710
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
18
Last Close Price
47.00EUR
Average target price
51.64EUR
Spread / Average Target
+9.87%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. BAYN Stock